1. Home
  2. BTSG vs BEAM Comparison

BTSG vs BEAM Comparison

Compare BTSG & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BTSG
  • BEAM
  • Stock Information
  • Founded
  • BTSG 1974
  • BEAM 2017
  • Country
  • BTSG United States
  • BEAM United States
  • Employees
  • BTSG N/A
  • BEAM N/A
  • Industry
  • BTSG
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BTSG
  • BEAM Health Care
  • Exchange
  • BTSG NYSE
  • BEAM Nasdaq
  • Market Cap
  • BTSG 2.0B
  • BEAM 1.9B
  • IPO Year
  • BTSG 2024
  • BEAM 2020
  • Fundamental
  • Price
  • BTSG $17.63
  • BEAM $23.93
  • Analyst Decision
  • BTSG Strong Buy
  • BEAM Buy
  • Analyst Count
  • BTSG 12
  • BEAM 10
  • Target Price
  • BTSG $16.86
  • BEAM $47.00
  • AVG Volume (30 Days)
  • BTSG 1.6M
  • BEAM 1.0M
  • Earning Date
  • BTSG 11-01-2024
  • BEAM 11-05-2024
  • Dividend Yield
  • BTSG N/A
  • BEAM N/A
  • EPS Growth
  • BTSG N/A
  • BEAM N/A
  • EPS
  • BTSG N/A
  • BEAM N/A
  • Revenue
  • BTSG $10,588,215,000.00
  • BEAM $349,643,000.00
  • Revenue This Year
  • BTSG $25.17
  • BEAM N/A
  • Revenue Next Year
  • BTSG $9.59
  • BEAM $9.04
  • P/E Ratio
  • BTSG N/A
  • BEAM N/A
  • Revenue Growth
  • BTSG 25.72
  • BEAM 328.73
  • 52 Week Low
  • BTSG $7.85
  • BEAM $18.85
  • 52 Week High
  • BTSG $17.68
  • BEAM $49.50
  • Technical
  • Relative Strength Index (RSI)
  • BTSG 68.91
  • BEAM 52.24
  • Support Level
  • BTSG $14.73
  • BEAM $21.79
  • Resistance Level
  • BTSG $17.54
  • BEAM $24.95
  • Average True Range (ATR)
  • BTSG 0.65
  • BEAM 1.31
  • MACD
  • BTSG 0.11
  • BEAM 0.15
  • Stochastic Oscillator
  • BTSG 98.31
  • BEAM 52.79

About BTSG BRIGHTSPRING HEALTH SERVICES INC

BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. Its platform delivers clinical services and pharmacy solutions across Medicare, Medicaid, and commercially insured populations. Its segments include Pharmacy Solutions, Provider Service. and others. It generates the majority of its revenue from the Pharmacy Solutions segment.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.

Share on Social Networks: